Introduction
In 1988, Jacobson defined the reversible renal impaircollected prior to or 4-8 weeks following angiography. The majority of patients had been referred for ment due to renal artery narrowing as ischaemic nephropathy.1 It is now recognized that the renal investigation of renal dysfunction rather than solely for investigation of hypertension. There was often a disease associated with atherosclerotic renal artery stenosis is more complex than just a direct response suspicion of renovascular disease at the time of referral. to ischaemia,2 and the processes may include focal segmental glomerulosclerosis (FSGS)3 and atheroTo ensure uniformity between the two centres during data analysis, GFR was calculated using the embolic disease.3,4 In many forms of renal disease, proteinuria is a predictor of progressive renal dysCockroft-Gault formula:6 function.5 Although there are individual case reports GFR (ml/min) or series, there has been no investigation into the =K [1.2×(140−age in years) frequency of proteinuria in atherosclerotic renovascu×weight in kg/plasma creatinine in mmol/l] lar disease (ARVD). We investigated the prevalence and magnitude of proteinuria in patients with ARVD.
Arterial anatomy was determined by digital subtraction angiography. Radiological findings were reported either as 'normal', 'stenosis' or 'occlusion'. Stenoses were graded as mild (<25%), moderate
Methods
(25-50%), or severe (>50%). Patients with proven ARVD were scored between 0 and 2, according to Patients from two renal centres with angiographically-confirmed ARVD were investigated to detera 'patency index' as follows: 0, occlusion in one vessel; 1, normal vessel; with intermediate values mine their renal function and degree of proteinuria. Protein was quantified from 24-h urine samples derived as 1 minus the degree of stenosis. A patient with 50% stenosis on one side and occlusion on the Results other would therefore score 0.5 (0.5+0), and a Patient characteristics are shown in Table 1 . Ninetypatient with bilateral 50% stenosis would score 1 four patients were available for study, 52 males and (0.5+0.5).
42 females (M5F=1.251), of whom 87 (92.6%) Data were also obtained for age at presentation, were on treatment for hypertension. Some were on sex, and the presence or absence of diabetes and angiotensin-converting-enzyme inhibitors (ACEIs) hypertension.
prior to diagnosis, but these were usually discontinued on suspicion or confirmation of the diagnosis
Correlation of GFR and proteinuria of ARVD. The mean age of the patients was 66 years (range 49-87). Patients were arbitrarily stratified into four groups according to their GFR (ml/min): <10 (n=9); [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] There were 20 diabetic patients, all of whom were type II diabetics. Five had substantial proteinuria (n=36); 25-50 (n=33); and >50 (n=16). Mean proteinuria as well as the standard error of the mean (mean 1.37 g) and all underwent renal biopsy. Features in keeping with diabetic nephropathy were (SEM) was calculated for each group (Figure 1 ). Statistical analysis was done using ANOVA, comparpresent in four, and these patients were excluded from data analysis. In the fifth patient, the biopsy ing all four groups of patients.
showed athero-emboli, but no evidence of diabetic nephropathy. The other 15 diabetics had lesser
Correlation of proteinuria and patency degrees of proteinuria (mean 0.58 g) and lacked
index clinical features such as retinopathy or peripheral neuropathy, which argued against diabetic nephroMean proteinuria was plotted against patency index in the scatter diagram shown in Figure 2 . There was pathy being comorbidly present with ARVD, but as renal biopsies were not performed on these patients, no correlation between the parameters (r=0.05).
it is impossible to be certain. The proteinuria increased significantly ( p<0.0325) in magnitude as GFR declined in these patients. We were concerned that the diabetic patients included in the study might skew these results. Subgroup analysis however, showed that there was an even distribution between groups, as seven of the 15 diabetics included had GFRs <25 ml/min. Similarly, there was no difference in prevalence of treated hypertension between the groups.
Biopsies were performed on seven non-diabetic patients who had substantial proteinuria; especially where there was a suspicion that there might be stenosis who had a biopsy performed on the contralateral kidney. FSGS was found in three patients (the immunofluorescence pattern suggested that this was secondary, rather than idiopathic FSGS), curing nephrotic range proteinuria, lends support for a central role for hyper-reninaemia. In their patient, glomerulosclerosis with marked ischaemic changes proteinuria fell gradually rather than instantaneously in two patients, and athero-embolic disease with after the nephrectomy, suggesting that the proteinuria cholesterol clefts in one diabetic patient in the did not originate solely from the kidney with the absence of overt diabetic changes ( Table 2) . occluded renal artery. In athero-embolic disease, the regular occurrence of proteinuria suggests a more direct response, perhaps due to cholesterol crystal Discussion embolization, which is occasionally associated with an acute-phase response. That FSGS can develop in This paper is a survey of patients followed by two a kidney with renal artery stenosis provokes interesrenal centres interested in ARVD. Most of our patients ting mechanistic hypotheses, which however, are had some degree of renal impairment, and as such difficult to prove.3 Although we only obtained biopsy might not be representative of the overall spectrum of material in a minority of our patients with ARVD, a ARVD. Biopsy findings were not available on most of spectrum of parenchymal disorders were observed. these patients, and thus the precise nature of the As the renal histological changes can be focal, we parenchymal disease causing the proteinuria could suggest that pathogenetic mechanisms can vary, and not be confirmed. However, these results do suggest that several distinct changes may co-exist in the that urine protein excretion above the normal range individual patient. We therefore feel the term 'atherois common in patients with ARVD. Indeed, proteinuria, sclerotic nephropathy' is a more appropriate term to even in excess of 2 g/day, may be a marker for describe the spectrum of renal disease associated atherosclerotic nephropathy, rather than an indicator with ARVD. of some other pathology as previously thought.
ACEIs are useful agents for attenuating proteinuria, The features of interest are the relationships but we have been reluctant to initiate the liberal use between proteinuria, renal function and patency of these agents in our patients pre-or postindex. The degree of proteinuria increased strikingly angioplasty. This is because of the progressive nature with declining renal function, and we believe this of the renal artery narrowing11 and the risk of reflects the severity of parenchymal damage in these restenosis following intervention.12 However, it is patients. These findings are noteworthy, as in most interesting that in Mikhail et al., three of the patients glomerulopathies, proteinuria tends to decline with with progressive renal dysfunction after angioplasty worsening renal function. This relationship between actually had 24-h urine protein values well above GFR and proteinuria is reminiscent of that seen in the normal range.13 Single kidney GFR estimations advanced diabetic nephropathy, the late stages of on these patients showed that progressive renal membranous nephropathy and 'chronic rejection' of dysfunction occurred independently of restenosis.13 renal allografts.
Significant proteinuria not uncommonly accompanData from Suresh et al. shows that there is no ies such functional deterioration, and as such, there correlation between renal function and the patency may yet be a rationale for ACEIs or angiotensin II index in patients with ARVD.7 This is in keeping receptor antagonists in the long-term treatment of with the lack of correlation between proteinuria and subgroups of patients with ARVD. The challenge for patency index demonstrated in our study. The poor the nephrologist will be to identify such subgroups. correlation between proteinuria and the patency index suggests that the proteinuria is due to events 'downstream' from the proximal arterial lesion rather
